Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 18, 2009
Absorption, disposition, metabolic fate, and elimination of the dopamine agonist rotigotine in man: administration by intravenous infusion or transdermal deliveryWilli Cawello, Marina Braun, Hilmar Boekens
European Journal of Drug Metabolism and Pharmacokinetics|January 15, 2018
Drug Delivery and Transport into the Central Circulation: An Example of Zero-Order In vivo Absorption of Rotigotine from a Transdermal Patch FormulationWilli Cawello, Marina Braun, Jens-Otto Andreas
British Journal of Clinical Pharmacology|December 20, 2008
Influence of domperidone on pharmacokinetics, safety and tolerability of the dopamine agonist rotigotineMarina Braun, Willi Cawello, Hilmar Boekens, et al.
European Journal of Drug Metabolism and Pharmacokinetics|September 21, 2013
Influence of hepatic impairment on the pharmacokinetics of the dopamine agonist rotigotineWilli Cawello, Andreas Fichtner, Hilmar Boekens, et al.
Circulation Research|June 1, 2002
Factor Xa releases matrix metalloproteinase-2 (MMP-2) from human vascular smooth muscle cells and stimulates the conversion of pro-MMP-2 to MMP-2: role of MMP-2 in factor Xa-induced DNA synthesis and matrix invasionBernhard H Rauch, Ellen Bretschneider, Marina Braun, et al.
The Journal of Physical Chemistry. A|February 9, 2010
Quantitative laser diagnostic and modeling study of C2 and CH chemistry in combustionMarkus Köhler, Andreas Brockhinke, Marina Braun-Unkhoff, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
No influence of the CYP2C19-selective inhibitor omeprazole on the pharmacokinetics of the dopamine receptor agonist rotigotineJan-Peer Elshoff, Willi Cawello, Jens-Otto Andreas, et al.
British Journal of Clinical Pharmacology|June 29, 2011
Single dose pharmacokinetics of the transdermal rotigotine patch in patients with impaired renal functionWilli Cawello, Sascha Ahrweiler, Wladyslaw Sulowicz, et al.
Journal of Clinical Pharmacology|July 25, 2009
Lack of pharmacokinetic interactions between transdermal rotigotine and oral levodopa/carbidopaMarina Braun, Willi Cawello, Jens-Otto Andreas, et al.
European Journal of Pharmacology|October 2, 2007
ICAM-1 and p38 MAPK mediate fibrinogen-induced migration of human vascular smooth muscle cellsBernhard H Rauch, Birgit Müschenborn, Marina Braun, et al.
Pageof 3